• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

奥美沙坦：引起的斑丘疹。

Olmesartan: induced maculopapular rash.

机构信息

Department of Pharmacology and Surgery, BIMS College, Belgaum, Karnataka, India.

出版信息

Indian J Pharmacol. 2013 Mar-Apr;45(2):199-200. doi: 10.4103/0253-7613.108325.

DOI:10.4103/0253-7613.108325
PMID:23716904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3660940/
Abstract

Olmesartan medoxomil is an angiotensin receptor blocker (ARB) which is shown to be effective and well tolerated in hypertensive patients. It is a frequently prescribed antihypertensive as it is considered safe. Here, we report the case of a patient who developed maculopapular rash during the course of the treatment with olmesartan medoxomil.

摘要

奥美沙坦酯是一种血管紧张素受体阻滞剂（ARB），已被证明在高血压患者中有效且耐受良好。它是一种常用的降压药，因为它被认为是安全的。在这里，我们报告了一例患者在服用奥美沙坦酯期间出现斑丘疹的病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae0c/3660940/89c1da8ccc62/IJPharm-45-199-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae0c/3660940/89c1da8ccc62/IJPharm-45-199-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae0c/3660940/89c1da8ccc62/IJPharm-45-199-g001.jpg

相似文献

1
Olmesartan: induced maculopapular rash.奥美沙坦：引起的斑丘疹。
Indian J Pharmacol. 2013 Mar-Apr;45(2):199-200. doi: 10.4103/0253-7613.108325.
2
Olmesartan medoxomil-induced angioedema.奥美沙坦酯所致血管性水肿。
Ann Pharmacother. 2007 Mar;41(3):518-20. doi: 10.1345/aph.1H566. Epub 2007 Mar 6.
3
Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).奥美沙坦与钙拮抗剂随机对照（OSCAR）研究的原理、设计及患者基线特征：一项比较日本老年高危高血压患者中高剂量血管紧张素II受体阻滞剂（ARB）单药治疗与ARB联合钙通道阻滞剂治疗心血管事件发生率的研究（ClinicalTrials.gov编号：NCT00134160）
Hypertens Res. 2009 Jul;32(7):575-80. doi: 10.1038/hr.2009.60. Epub 2009 May 15.
4
Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.奥美沙坦酯片治疗轻至中度原发性高血压患者的疗效和耐受性：OLMEBEST研究
Clin Drug Investig. 2007;27(8):545-58. doi: 10.2165/00044011-200727080-00003.
5
Antihypertensive effects of olmesartan compared with other angiotensin receptor blockers: a meta-analysis.奥美沙坦与其他血管紧张素受体阻滞剂的降压效果比较：一项荟萃分析。
Am J Cardiovasc Drugs. 2012 Oct 1;12(5):335-44. doi: 10.1007/BF03261842.
6
Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, multinational, phase III study.奥美沙坦酯氢氯噻嗪复方 40/12.5 毫克治疗中重度高血压患者的疗效和安全性：一项随机、双盲、平行分组、多中心、多国、III 期研究。
Clin Drug Investig. 2010;30(9):581-97. doi: 10.2165/11536710-000000000-00000.
7
Antihypertensive efficacy of olmesartan medoxomil and ramipril in elderly patients with mild to moderate hypertension grouped according to renal function status : a retrospective analysis.根据肾功能状态分组的老年轻度至中度高血压患者中奥美沙坦酯与雷米普利的降压疗效：一项回顾性分析
High Blood Press Cardiovasc Prev. 2012 Dec;19(4):213-22. doi: 10.1007/BF03297633. Epub 2013 Feb 19.
8
Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study.氨氯地平单药治疗后奥美沙坦酯与氨氯地平联合应用于中重度高血压患者的疗效和耐受性：一项随机、双盲、平行组、多中心研究。
Clin Drug Investig. 2009;29(1):11-25. doi: 10.2165/0044011-200929010-00002.
9
Olmesartan-induced enteropathy treated with budesonide.布地奈德治疗奥美沙坦所致肠病
Acta Gastroenterol Belg. 2019 Apr-Jun;82(2):319-321.
10
Olmesartan medoxomil: an angiotensin II-receptor blocker.奥美沙坦酯：一种血管紧张素II受体阻滞剂。
Clin Ther. 2003 Apr;25(4):1041-55. doi: 10.1016/s0149-2918(03)80066-8.

引用本文的文献

1
Olmesartan-induced enteropathy associated with cutaneous lesions.奥美沙坦所致肠病伴皮肤损害
Clin Case Rep. 2016 Mar 2;4(4):379-82. doi: 10.1002/ccr3.531. eCollection 2016 Apr.

本文引用的文献

1
Exanthematous drug eruption due to valsartan.缬沙坦引起的药疹。
Cutan Ocul Toxicol. 2012 Dec;31(4):335-7. doi: 10.3109/15569527.2011.647179. Epub 2012 Jan 18.
2
Comparative assessment of angiotensin receptor blockers in different clinical settings.不同临床环境中血管紧张素受体阻滞剂的比较评估。
Vasc Health Risk Manag. 2009;5:939-48. doi: 10.2147/vhrm.s7263. Epub 2009 Nov 16.
3
Comparative safety and tolerability of angiotensin II receptor antagonists.血管紧张素II受体拮抗剂的比较安全性和耐受性
Drug Saf. 1999 Jul;21(1):23-33. doi: 10.2165/00002018-199921010-00003.
4
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE).氯沙坦与卡托普利治疗65岁以上心力衰竭患者的随机试验（老年氯沙坦评估研究，ELITE）
Lancet. 1997 Mar 15;349(9054):747-52. doi: 10.1016/s0140-6736(97)01187-2.